Journey Medical Corporation
DERM
$7.69
$0.283.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.43% | 14.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.47% | 14.23% | |||
| Cost of Revenue | 16.52% | 3.11% | |||
| Gross Profit | 17.93% | 20.61% | |||
| SG&A Expenses | 1.45% | 12.42% | |||
| Depreciation & Amortization | 0.00% | -0.09% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.13% | 8.64% | |||
| Operating Income | 46.84% | 13.48% | |||
| Income Before Tax | 38.04% | 8.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.01% | 6.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.01% | 6.80% | |||
| EBIT | 46.84% | 13.48% | |||
| EBITDA | 74.34% | 19.79% | |||
| EPS Basic | 43.07% | 9.49% | |||
| Normalized Basic EPS | 42.17% | 10.92% | |||
| EPS Diluted | 43.07% | 9.49% | |||
| Normalized Diluted EPS | 42.17% | 10.92% | |||
| Average Basic Shares Outstanding | 7.16% | 3.01% | |||
| Average Diluted Shares Outstanding | 7.16% | 3.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||